U.S. flag

An official website of the United States government

NM_005159.5(ACTC1):c.514G>A (p.Ala172Thr) AND not specified

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Dec 28, 2011
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000223912.1

Allele description [Variation Report for NM_005159.5(ACTC1):c.514G>A (p.Ala172Thr)]

NM_005159.5(ACTC1):c.514G>A (p.Ala172Thr)

Genes:
GJD2-DT:GJD2 divergent transcript [Gene - HGNC]
ACTC1:actin alpha cardiac muscle 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
15q14
Genomic location:
Preferred name:
NM_005159.5(ACTC1):c.514G>A (p.Ala172Thr)
HGVS:
  • NC_000015.10:g.34792510C>T
  • NG_007553.1:g.8217G>A
  • NM_005159.5:c.514G>AMANE SELECT
  • NP_005150.1:p.Ala172Thr
  • LRG_388t1:c.514G>A
  • LRG_388:g.8217G>A
  • NC_000015.9:g.35084711C>T
  • NM_005159.4:c.514G>A
Protein change:
A172T
Links:
dbSNP: rs876661340
NCBI 1000 Genomes Browser:
rs876661340
Molecular consequence:
  • NM_005159.5:c.514G>A - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000280037Stanford Center for Inherited Cardiovascular Disease, Stanford University
no assertion criteria provided
Uncertain significance
(Dec 28, 2011)
germlineclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot provided1not providednot providednot providednot providedclinical testing

Details of each submission

From Stanford Center for Inherited Cardiovascular Disease, Stanford University, SCV000280037.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testingnot provided

Description

Note this variant was found in clinical genetic testing performed by one or more labs who may also submit to ClinVar. Thus any internal case data may overlap with the internal case data of other labs. The interpretation reviewed below is that of the Stanford Center for Inherited Cardiovascular Disease. Based on the data reviewed below we consider this variant to be of uncertain significance. This variant has not been reported in association with cardiomyopathy. In silico analysis with PolyPhen-2 predicts the variant to be benign. This is a non-conservative amino acid substitution at a highly conserved position. No other variants have been reported in association with disease at this codon, though they have been reported at nearby codons (p.Tyr168Cys, p.Pro166Ala). In total the variant has been seen in 1 of 5570 laboratory controls and publicly available population datasets. This variant was observed in 1 out of 270 control individuals analyzed at GeneDx. There is no variation at codon 172 listed in the NHLBI Exome Sequencing Project dataset, which currently includes variant calls on ~6,500 Caucasian and African American individuals (as of 24 July 2013). There is also no variation at this codon listed in dbSNP or 1000 genomes (as of 24 July 2013).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot provided1not providednot providednot provided

Last Updated: Nov 5, 2022